Why the study?
Can controls from a test-negative vaccine effectiveness case-control study be used to accurately estimate population vaccination coverage?
Can controls from a test-negative vaccine effectiveness case-control study be used to accurately estimate population vaccination coverage?
Controls from a vaccine effectiveness case-control study can provide valid estimates of population vaccination coverage when reasonable assumptions are met.
Answers are grounded in this paper and cite their sources.
Supports using test-negative controls to estimate rotavirus coverage; leaves open generalizability to other vaccines and settings.
Vaccination program evaluation includes assessment of vaccine uptake and direct vaccine effectiveness (VE). Often examined separately, we propose a design to estimate rotavirus vaccination coverage using controls from a rotavirus VE test-negative case-control study and to examine coverage following implementation of the Quebec, Canada, rotavirus vaccination program. We present our assumptions for using these data as a proxy for coverage in the general population, explore effects of diagnostic accuracy on coverage estimates via simulations, and validate estimates with an external source. We found 79.0% (95% confidence interval, 74.3%, 83.0%) ≥2-dose rotavirus coverage among participants eligible for publicly funded vaccination. No differences were detected between study and external coverage estimates. Simulations revealed minimal bias in estimates with high diagnostic sensitivity and specificity. We conclude that controls from a VE case-control study may be a valuable resource of coverage information when reasonable assumptions can be made for estimate generalizability; high rotavirus coverage demonstrates success of the Quebec program.
No takes yet. Share an insight, caveat, or question.
Doll et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: